The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.
The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.
Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.
Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.
“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”
The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.
Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:
Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.
The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure organs and tissues organs damaged by various factors such as aging, trauma, and can also be used to provide stability of health in congenital disorders such ... View more
Proteinase K is a serine protease produced by the fungus Tritirachium album Limber. It is used as enzyme or reagent in different chemical reactions. It digests the unwanted nuclease in protein purification and produces pure sample of high molecular weight DNA... View more
Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. It is used to accelerate the healing of injured tendons, ligaments, muscles and joints. ... View more
Definition of Market/Industry: Biophotonics is a branch of science that deals with producing and using the photons of light to create an image, identify, and engineer biological materials. Biophotonics is a combina... View more
Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory. These eggs are then mixed with sperms to form embryos. ART procedu... View more
Cervical Cancer Vaccines Market – Insights Cervical cancer is currently the leading cause of cancer mortality among women worldwide. According to World Health Organization 2018, around 90% of deaths fro... View more
Stem cells are derived from the human cells. Stem cell therapy is also known as regenerative medicine. Regenerative medicine refers to a group of biomedical approaches (such as tissue engineering), which involves adoption of stem cells. These therapies have the abilit... View more
Nucleic acid sequence-based amplification is a type of method in molecular biology, which is used to amplify RNA sequences. Isothermal Nucleic acid Amplification Technology (INAAT) is segregated into several methods such as transcription mediated amplification, nuclei... View more
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug resistant bacteria. When all antibiotics fail to work against ... View more
Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Custom recombinant protein production is one of the efficient techniques used in life sciences sector that play a major role in advanced healthcare. Proteins are manipulat... View more
Increasing collaborations among key players to develop and introduce vaccines for pneumococcal and meningococcal diseases in the market and ongoing clinical trial studies on pneumococcal vaccines are expe... View more
Lifescience Reagent Market Insights Increasing prevalence of infectious disease, which requires early diagnosis is creating the opportunity for the biotechnology industry players to produce effective reagents... View more
Gel electrophoresis devices are used for the separation of nucleic acids and proteins based on their charge and size. These devices are mainly used in forensic investigation, molecular biology, genetics, and microbiological labs. Electrophoresis is used for analyzing ... View more
Biologics Market – Insights A biologic drug (biologics) is a product that is produced from living organisms or contain components of living organisms. New technologies and novel therapies are emerging... View more
Increasing number of orthopedic surgeries, trauma cases, and dental graft implant procedures are expected to support growth of the Latin America bone graft and substitutes market over the forecast period. Rapid increase in adoption of ... View more
Antibody, also called as immunoglobulin, is a protein produced by plasma cells in response to specific antigens. These antibodies can be used as therapeutic as well as diagnostic purposes for several indications... View more
Sterile Filtration Market – Insights Sterile filtration is used in pharmaceutical industry to prevent microbial contamination. The process minimizes the risk of microbial contamination in patients by of... View more
Biomarker Research Services Market – Insights Biomarkers are increasingly being used in all areas of medicine to help predict and characterize disease. The increasing focus on biomarkers is expected to ... View more